Table 2.
CCDC88A expression | P | ||||
---|---|---|---|---|---|
Low | High | ||||
Stagea | percentage (%) | 0.938 | |||
0 | 2.6 | [n = 2] | 0 | [n = 0] | |
IA | 3.9 | [n = 3] | 4.0 | [n = 1] | |
IB | 7.8 | [n = 6] | 8.0 | [n = 2] | |
IIA | 29.9 | [n = 23] | 36.0 | [n = 9] | |
IIB | 50.6 | [n = 39] | 44.0 | [n = 11] | |
III | 1.3 | [n = 1] | 4.0 | [n = 1] | |
IV | 3.9 | [n = 3] | 4.0 | [n = 1] | |
Primary tumora | 0.656 | ||||
Tis | 2.6 | [n = 2] | 0 | [n = 0] | |
T1 | 6.5 | [n = 5] | 4.0 | [n = 1] | |
T2 | 13.0 | [n = 10] | 20.0 | [n = 5] | |
T3 | 76.6 | [n = 59] | 72.0 | [n = 18] | |
T4 | 1.3 | [n = 1] | 4.0 | [n = 1] | |
Regional lymph nodesa | 0.644 | ||||
N0 | 44.2 | [n = 34] | 52.0 | [n = 13] | |
N1 | 55.8 | [n = 43] | 48.0 | [n = 12] | |
Distant metastasisa | 1 | ||||
M0 | 96.1 | [n = 74] | 96.0 | [n = 24] | |
M1 | 3.9 | [n = 3] | 4.0 | [n = 1] | |
Histologyb | 0.9391 | ||||
PanIN | 2.6 | [n = 2] | 0 | [n = 0] | |
Well | 29.9 | [n = 23] | 32.0 | [n = 8] | |
Moderate | 54.5 | [n = 42] | 60.0 | [n = 15] | |
Poor | 13.0 | [n = 10] | 8.0 | [n = 2] | |
Venous invasionb | 0.741 | ||||
v0 + v1 | 87 | [n = 67] | 84.0 | [n = 21] | |
V2 + v3 | 13 | [n = 10] | 16.0 | [n = 4] | |
Lymphatic invasionb | 0.789 | ||||
ly0 + ly1 | 76.6 | [n = 59] | 72.0 | [n = 18] | |
ly2 + ly3 | 23.4 | [n = 18] | 28.0 | [n = 7] | |
Recurrence | 0.133 | ||||
Yes | 67.5 | [n = 52] | 84.0 | [n = 21] | |
No | 22.5 | [n = 25] | 16.0 | [n = 4] |
aClassified according to the classification of International Union against Cancer
bClassified according to the classification of pancreatic cancer of Japan Pancreas Society; PanIN, pancreatic intraepithelial neoplasia